Cardeza Foundation for Hematologic Research, Department of Medicine, Sidney Kimmel Medical College, Thomas Jefferson University, 1020 Locust Street Suite 394, Philadelphia, PA, 19107, USA.
Division of Hematology/Oncology/BMT, Department of Pediatrics, Emory University School of Medicine, Children's Healthcare of Atlanta, Emory Healthcare, Atlanta, GA, USA.
Ann Hematol. 2020 Nov;99(11):2483-2495. doi: 10.1007/s00277-020-04205-0. Epub 2020 Aug 27.
Sickle cell disease (SCD), a genetic disorder affecting up to 100,000 patients in the USA, impacts multiple organ systems. The emergency department (ED) is frequently utilized by patients with SCD who have severe pain from vaso-occlusive crises. The goal of this systematic literature review is to identify predictors for ED use among patients with SCD in the USA, as high ED reliance is not ideal because of the potential for discontinuity of care as well as higher costs. PubMed and Embase were searched for articles containing the keywords "sickle cell disease" AND ("emergency" OR "acute care") AND ("utilization" OR "health care") published between 2000 and 26 September 2019. A total of 26 publications were identified meeting the following inclusion criteria: report of ED or acute care clinic use; report of health care utilization for SCD; and report of ED visits independent of hospital admission, ED revisits, inpatient care visits, and SCD care unit visits. Articles unavailable in English or those focused on populations outside the USA were excluded. Of the 26 articles included, 4 were prospective and the remainder were retrospective. Qualitative analysis of the articles revealed a higher rate of ED utilization among adults than children, patients with public insurance than private insurance, and patients with more comorbidities, complications, or pain. Age and pain levels were both commonly cited as predictors of ED utilization. Additional prospective and interventional studies are needed to further define predictors of ED utilization and to uncover treatments that decrease ED visits.
镰状细胞病(SCD)是一种影响美国多达 10 万名患者的遗传性疾病,影响多个器官系统。患有血管阻塞性危象导致严重疼痛的 SCD 患者经常会去急诊科就诊。本系统文献综述的目的是确定美国 SCD 患者去急诊科就诊的预测因素,因为过度依赖急诊科就诊并不理想,因为可能会中断治疗,并且成本更高。在 2000 年至 2019 年 9 月 26 日期间,在 PubMed 和 Embase 上搜索了包含关键字“sickle cell disease”AND(“emergency”或“acute care”)AND(“utilization”或“health care”)的文章,共确定了 26 篇符合以下纳入标准的文章:报告 ED 或急性护理诊所的使用;报告 SCD 的医疗保健利用情况;以及报告 ED 就诊,不包括住院、ED 复诊、住院护理就诊和 SCD 护理病房就诊。排除了英文不可用或关注美国以外人群的文章。在纳入的 26 篇文章中,有 4 篇是前瞻性的,其余的是回顾性的。对这些文章进行定性分析发现,成年人比儿童、公共保险患者比私人保险患者、合并症、并发症或疼痛更多的患者去急诊科就诊的比率更高。年龄和疼痛程度都是 ED 就诊的常见预测因素。需要进一步开展前瞻性和干预性研究,以进一步确定 ED 就诊的预测因素,并发现减少 ED 就诊的治疗方法。